Anthony Weiss

Anthony Weiss, M.D.

Associate Professor of Psychiatry, Beth Israel Deaconess Medical Center
Temporary Academic, Harvard Medical School
Faculty Member of the Center for Bioethics
Member, HMS Center for Bioethics

Anthony Weiss, MD, MBA, MSc is the Chief Medical Officer at Beth Israel Deaconess Medical Center and an Associate Professor of Psychiatry at Harvard Medical School. He received his BS (Pharmacology) and MD from the University of Wisconsin - Madison. He also received a MSc (Medical Science) from Harvard Medical School, and an MBA from the FW Olin Graduate School of Business at Babson College. His primary focus is on healthcare quality, particularly process improvement, and on the concept of creating learning organizations within healthcare. His bioethical interests relate to the impact of technology and change on the doctor-patient relationship, as well as the tension between physician autonomy and regulatory oversite in managing these changes.

Publications View
Aberrant frontoparietal function during recognition memory in schizophrenia: a multimodal neuroimaging investigation.
Authors: Authors: Weiss AP, Ellis CB, Roffman JL, Stufflebeam S, Hamalainen MS, Duff M, Goff DC, Schacter DL.
J Neurosci
View full abstract on Pubmed
Closing the efficacy-effectiveness gap: translating both the what and the how from randomized controlled trials to clinical practice.
Authors: Authors: Weiss AP, Guidi J, Fava M.
J Clin Psychiatry
View full abstract on Pubmed
Quality improvement in healthcare: the six ps of root-cause analysis.
Authors: Authors: Weiss AP.
Am J Psychiatry
View full abstract on Pubmed
MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met.
Authors: Authors: Roffman JL, Gollub RL, Calhoun VD, Wassink TH, Weiss AP, Ho BC, White T, Clark VP, Fries J, Andreasen NC, Goff DC, Manoach DS.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia.
Authors: Authors: Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Wong DH, Halsted CH, Goff DC.

View full abstract on Pubmed
No evidence for a differential deficit of reality monitoring in schizophrenia: a meta-analysis of the associative memory literature.
Authors: Authors: Achim AM, Weiss AP.
Cogn Neuropsychiatry
View full abstract on Pubmed
Reach of benchmark psychiatric trial results to community-based providers: a case study of CATIE.
Authors: Authors: Petersen TJ, Huffman JC, Weiss AP, Blais MA, Andreotti CF, Horwitz MB, Birnbaum RJ.
J Clin Psychiatry
View full abstract on Pubmed
Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.
Authors: Authors: Jubelt LE, Barr RS, Goff DC, Logvinenko T, Weiss AP, Evins AE.
Psychopharmacology (Berl)
View full abstract on Pubmed
Distinguishing familiarity-based from source-based memory performance in patients with schizophrenia.
Authors: Authors: Weiss AP, Goff DC, Duff M, Roffman JL, Schacter DL.
Schizophr Res
View full abstract on Pubmed
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
Authors: Authors: Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE.
Neuropsychopharmacology
View full abstract on Pubmed